Does caffeine intake protect from Alzheimer's disease?

European Journal of Neurology

Volumn 9, Issue 4, 2002, Pages 377-382

  Maia, L ^a   De Mendonca A ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Alzheimer's disease; Caffeine; Decreased risk; Neuroprotection; Risk factor; Xanthine

Indexed keywords

ALPHA TOCOPHEROL; CAFFEINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; COGNITION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DRUG EFFECT; EDUCATION; FAMILY HISTORY; FEMALE; FOOD INTAKE; HEAD INJURY; HEART DISEASE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; STOMACH DISEASE; STROKE;

AGED; ALZHEIMER DISEASE; CAFFEINE; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; QUESTIONNAIRES; RISK FACTORS;

EID: 0036046427     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00421.x     Document Type: Article

References (30)

1. Alzheimer's disease: A review of the disease, its epidemiology and economic impact
2. Caffeine consumption
3. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease
4. Reliability of information collected by proxy in family studies of Alzheimer's disease
5. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
6. A comparison of familial and sporadic Alzheimer's disease
7. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
8. Epidemiology of Alzheimer's disease: Issues of etiology and validity
9. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
10. Cerebral cortex pathology in aging and Alzheimer's disease. A quantitative survey of large hospital-based geriatric and psychiatric cohorts
11. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
12. Clinical trials in dementia with propentofylline
13. Coffee consumption and the risk of coronary heart disease and death
14. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
15. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses
16. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort
17. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
18. Adenosine: Does it have a neuroprotective role after all?
19. Incidence and risk of dementia: The Rotterdam study
20. A case-control study of caffeinated beverages and pre-term delivery
21. Information available from surrogate respondents in case-control interview studies
22. N-acetyltransferase (NAT2) genotype and susceptibility to sporadic Alzheimer's disease
23. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
24. Association of coffee and caffeine intake with the risk of Parkinson disease
25. Alzheimer's disease after remote head injury: An incidence study
26. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
27. The course of cognitive impairment in preclinical Alzheimer disease. Three- and 6-year follow-up of a population-based sample
28. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
29. Caffeine intake in relation to the risk of primary cardiac arrest